Self-Monitoring Blood Glucose Test Systems for Over-the-Counter Use; Draft Guidance for Industry and Food and Drug Administration Staff; Availability

Docket ID: FDA-2013-D-1446
Agency: Food and Drug Administration (FDA)
Parent Agency: Department of Health and Human Services (HHS)
Docket Details open glossary dialog  
Related RINs: None
Related Dockets: None
Keyword(s): cdrh, cdrh2013111, open
Type: Nonrulemaking
Docket Status: open
Center: CDRH
Docket Item Code: D

Primary Documents

View All  (3)
Comment Period Closed
May 07, 2014 11:59 PM ET
Posted: 04/09/2014
ID: FDA-2013-D-1446-0003
Comment Period Closed
Apr 07, 2014 11:59 PM ET
Posted: 01/07/2014
ID: FDA-2013-D-1446-0001

Supporting Documents

No documents available.


View All  (10)

Comments Received*
*This count refers to the total comment/submissions received on this docket, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.